Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1988 Nov;34:[2365], 2521-[2526].

Intravenous IgG: A New Therapeutic Tool

Lynn K Boshkov, John G Kelton
PMCID: PMC2219018  PMID: 21253124

Abstract

Since the 1950s, intramuscular gammaglobulin preparations have been used for antibody replacement in patients with immune deficiency syndromes. The authors of this article discuss newer intravenous formulations which have expanded the role of IgG preparations from simple antibody replacement to therapeutic use in high doses as an immune suppressant and an autoimmune modulator.

Keywords: immune seroglobulin, immune deficiency syndrome

Full text

PDF
2365

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumgartner J. D., Glauser M. P. Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient. Rev Infect Dis. 1987 Jan-Feb;9(1):194–205. doi: 10.1093/clinids/9.1.194. [DOI] [PubMed] [Google Scholar]
  2. Berger M., Cupps T. R., Fauci A. S. Immunoglobulin replacement therapy by slow subcutaneous infusion. Ann Intern Med. 1980 Jul;93(1):55–56. doi: 10.7326/0003-4819-93-1-55. [DOI] [PubMed] [Google Scholar]
  3. Björkander J., Cunningham-Rundles C., Lundin P., Olsson R., Söderström R., Hanson L. A. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med. 1988 Jan;84(1):107–111. doi: 10.1016/0002-9343(88)90016-2. [DOI] [PubMed] [Google Scholar]
  4. Bussel J. B., Hilgartner M. W. Intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura in childhood and adolescence. Hematol Oncol Clin North Am. 1987 Sep;1(3):465–482. [PubMed] [Google Scholar]
  5. Bussel J. B., Pham L. C. Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of the literature. Vox Sang. 1987;52(3):206–211. doi: 10.1111/j.1423-0410.1987.tb03029.x. [DOI] [PubMed] [Google Scholar]
  6. Bussel J. Intravenous immune serum globulin in immune thrombocytopenia: clinical results and biochemical evaluation. Vox Sang. 1985;49 (Suppl 1):44–50. doi: 10.1111/j.1423-0410.1985.tb01143.x. [DOI] [PubMed] [Google Scholar]
  7. Bussel J., Lalezari P., Hilgartner M., Partin J., Fikrig S., O'Malley J., Barandun S. Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy. Blood. 1983 Aug;62(2):398–400. [PubMed] [Google Scholar]
  8. Bussell J. Therapy in cytopenia. Vox Sang. 1986;51 (Suppl 2):69–73. doi: 10.1111/j.1423-0410.1986.tb02011.x. [DOI] [PubMed] [Google Scholar]
  9. Calvelli T. A., Rubinstein A. Intravenous gamma-globulin in infant acquired immunodeficiency syndrome. Pediatr Infect Dis. 1986 May-Jun;5(3 Suppl):S207–S210. [PubMed] [Google Scholar]
  10. Copelan E. A., Strohm P. L., Kennedy M. S., Tutschka P. J. Hemolysis following intravenous immune globulin therapy. Transfusion. 1986 Sep-Oct;26(5):410–412. doi: 10.1046/j.1537-2995.1986.26587020113.x. [DOI] [PubMed] [Google Scholar]
  11. Cross A. S., Alving B. M., Sadoff J. C., Baldwin P., Terebelo H., Tang D. Intravenous immune globulin: a cautionary note. Lancet. 1984 Apr 21;1(8382):912–912. doi: 10.1016/s0140-6736(84)91376-x. [DOI] [PubMed] [Google Scholar]
  12. DERBY B. M., ROGERS D. E. Studies on bacteriemia. V. The effect of simultaneous leukopenia and reticuloendothelial blockade on the early blood stream clearance of staphylococci and Escherichia coli. J Exp Med. 1961 Jun 1;113:1053–1066. doi: 10.1084/jem.113.6.1053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fehr J., Hofmann V., Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med. 1982 May 27;306(21):1254–1258. doi: 10.1056/NEJM198205273062102. [DOI] [PubMed] [Google Scholar]
  14. Heiner D. C. IgG subclass composition of intravenous immunoglobulin preparations: clinical relevance. Rev Infect Dis. 1986 Jul-Aug;8 (Suppl 4):S391–S395. doi: 10.1093/clinids/8.supplement_4.s391. [DOI] [PubMed] [Google Scholar]
  15. Imbach P., Barandun S., d'Apuzzo V., Baumgartner C., Hirt A., Morell A., Rossi E., Schöni M., Vest M., Wagner H. P. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981 Jun 6;1(8232):1228–1231. doi: 10.1016/s0140-6736(81)92400-4. [DOI] [PubMed] [Google Scholar]
  16. Karpatkin S. Autoimmune thrombocytopenic purpura. Semin Hematol. 1985 Oct;22(4):260–288. [PubMed] [Google Scholar]
  17. Kelton J. G. Advances in the diagnosis and management of ITP. Hosp Pract (Off Ed) 1985 Jun 15;20(6):95-99, 102-7. doi: 10.1080/21548331.1985.11703075. [DOI] [PubMed] [Google Scholar]
  18. Laurian Y., Le Bras P., Ellrodt A., Alvin P. Immune thrombocytopenia gammaglobulin, and positivity to the human T-lymphotropic virus type III. Ann Intern Med. 1986 Jul;105(1):145–146. doi: 10.7326/0003-4819-105-1-145_3. [DOI] [PubMed] [Google Scholar]
  19. Leahy M. F. Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia. Lancet. 1986 Jul 5;2(8497):48–48. doi: 10.1016/s0140-6736(86)92595-x. [DOI] [PubMed] [Google Scholar]
  20. Leen C. L., Yap P. L., McClelland D. B. Increase of serum immunoglobulin level into the normal range in primary hypogammaglobulinaemia by dosage individualization of intravenous immunoglobulin. Vox Sang. 1986;51(4):278–286. doi: 10.1111/j.1423-0410.1986.tb01969.x. [DOI] [PubMed] [Google Scholar]
  21. Long A. A., Denburg J. A., Dent P. B. Hypogammaglobulinemia: therapeutic rationale. CMAJ. 1987 Nov 1;137(9):793–797. [PMC free article] [PubMed] [Google Scholar]
  22. Minnefor A. B., Oleske J. M. I.v. immune globulin: efficacy and safety. Hosp Pract (Off Ed) 1987 Oct 15;22(10):171-3, 177-9, 182-3 passim. doi: 10.1080/21548331.1987.11703341. [DOI] [PubMed] [Google Scholar]
  23. Ochs H. D., Fischer S. H., Wedgwood R. J., Wara D. W., Cowan M. J., Ammann A. J., Saxon A., Budinger M. D., Allred R. U., Rousell R. H. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Am J Med. 1984 Mar 30;76(3A):78–82. doi: 10.1016/0002-9343(84)90324-3. [DOI] [PubMed] [Google Scholar]
  24. Ordi J., Vilardell M., Alijotas J., Barquinero J., Vila M. Serum thrombocytopenia and high-dose immunoglobulin treatment. Ann Intern Med. 1986 Feb;104(2):282–283. doi: 10.7326/0003-4819-104-2-282_2. [DOI] [PubMed] [Google Scholar]
  25. Pollack S., Cunningham-Rundles C., Smithwick E. M., Barandun S., Good R. A. High-dose intravenous gamma globulin for autoimmune neutropenia. N Engl J Med. 1982 Jul 22;307(4):253–253. doi: 10.1056/NEJM198207223070420. [DOI] [PubMed] [Google Scholar]
  26. Rousell R. H., Good R. A., Pirofsky B., Schiff R. I. Non-A non-B hepatitis and the safety of intravenous immune globulin, pH 4.2: a retrospective survey. Preliminary communication. Vox Sang. 1988;54(1):6–13. doi: 10.1111/j.1423-0410.1988.tb01605.x. [DOI] [PubMed] [Google Scholar]
  27. Salama A., Kiefel V., Mueller-Eckhardt C. Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol. 1986 Jul;22(3):241–250. doi: 10.1002/ajh.2830220304. [DOI] [PubMed] [Google Scholar]
  28. Schiff R. I., Rudd C., Johnson R., Buckley R. H. Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage. Clin Immunol Immunopathol. 1984 Apr;31(1):13–23. doi: 10.1016/0090-1229(84)90185-5. [DOI] [PubMed] [Google Scholar]
  29. Schur P. H. IgG subclasses--a review. Ann Allergy. 1987 Feb;58(2):89-96, 99. [PubMed] [Google Scholar]
  30. Sorensen R. U., Polmar S. H. Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes. Am J Med. 1984 Mar 30;76(3A):83–90. doi: 10.1016/0002-9343(84)90325-5. [DOI] [PubMed] [Google Scholar]
  31. Stiehm E. R., Ashida E., Kim K. S., Winston D. J., Haas A., Gale R. P. Intravenous immunoglobulins as therapeutic agents. Ann Intern Med. 1987 Sep;107(3):367–382. doi: 10.7326/0003-4819-107-2-367. [DOI] [PubMed] [Google Scholar]
  32. Sultan Y., Kazatchkine M. D., Maisonneuve P., Nydegger U. E. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet. 1984 Oct 6;2(8406):765–768. doi: 10.1016/s0140-6736(84)90701-3. [DOI] [PubMed] [Google Scholar]
  33. Williams P. E., Yap P. L., McClelland D. B. Dose of intravenous IgG in primary hypogammaglobulinaemia. Lancet. 1987 Jun 20;1(8547):1435–1436. doi: 10.1016/s0140-6736(87)90626-x. [DOI] [PubMed] [Google Scholar]
  34. Winston D. J., Ho W. G., Lin C. H., Bartoni K., Budinger M. D., Gale R. P., Champlin R. E. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med. 1987 Jan;106(1):12–18. doi: 10.7326/0003-4819-106-1-12. [DOI] [PubMed] [Google Scholar]
  35. Woodruff R. K., Grigg A. P., Firkin F. C., Smith I. L. Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients. Lancet. 1986 Jul 26;2(8500):217–218. doi: 10.1016/s0140-6736(86)92511-0. [DOI] [PubMed] [Google Scholar]
  36. von Muralt G., Sidiropoulos D. Experience with intravenous immunoglobulin treatment in neonates and pregnant women. Vox Sang. 1986;51 (Suppl 2):22–29. doi: 10.1111/j.1423-0410.1986.tb02003.x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES